ENSG vs. CPRX
Compare and contrast key facts about The Ensign Group, Inc. (ENSG) and Catalyst Pharmaceuticals, Inc. (CPRX).
Performance
ENSG vs. CPRX - Performance Comparison
Loading graphics...
ENSG vs. CPRX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ENSG The Ensign Group, Inc. | 15.71% | 31.33% | 18.62% | 18.89% | 12.98% | 15.43% | 61.43% | 25.53% | 75.67% | 0.78% |
CPRX Catalyst Pharmaceuticals, Inc. | 6.08% | 11.84% | 24.15% | -9.62% | 174.74% | 102.69% | -10.93% | 95.31% | -50.90% | 272.38% |
Fundamentals
ENSG:
$11.95B
CPRX:
$3.15B
ENSG:
$5.83
CPRX:
$1.68
ENSG:
34.53
CPRX:
14.71
ENSG:
2.28
CPRX:
0.26
ENSG:
2.35
CPRX:
5.35
ENSG:
5.35
CPRX:
3.30
ENSG:
$5.06B
CPRX:
$588.99M
ENSG:
$862.97M
CPRX:
$726.82M
ENSG:
$563.95M
CPRX:
$257.78M
Returns By Period
In the year-to-date period, ENSG achieves a 15.71% return, which is significantly higher than CPRX's 6.08% return. Over the past 10 years, ENSG has underperformed CPRX with an annualized return of 25.55%, while CPRX has yielded a comparatively higher 35.35% annualized return.
ENSG
- 1D
- 0.58%
- 1M
- -5.89%
- YTD
- 15.71%
- 6M
- 16.71%
- 1Y
- 55.95%
- 3Y*
- 28.48%
- 5Y*
- 16.79%
- 10Y*
- 25.55%
CPRX
- 1D
- 4.12%
- 1M
- 7.28%
- YTD
- 6.08%
- 6M
- 25.69%
- 1Y
- 2.10%
- 3Y*
- 14.30%
- 5Y*
- 40.58%
- 10Y*
- 35.35%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ENSG vs. CPRX — Risk / Return Rank
ENSG
CPRX
ENSG vs. CPRX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for The Ensign Group, Inc. (ENSG) and Catalyst Pharmaceuticals, Inc. (CPRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ENSG | CPRX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 2.05 | 0.06 | +1.99 |
Sortino ratioReturn per unit of downside risk | 3.20 | 0.32 | +2.87 |
Omega ratioGain probability vs. loss probability | 1.40 | 1.04 | +0.36 |
Calmar ratioReturn relative to maximum drawdown | 4.45 | 0.01 | +4.44 |
Martin ratioReturn relative to average drawdown | 11.94 | 0.02 | +11.92 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| ENSG | CPRX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.05 | 0.06 | +1.99 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.64 | 0.85 | -0.21 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.71 | 0.56 | +0.15 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.62 | 0.08 | +0.55 |
Correlation
The correlation between ENSG and CPRX is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
ENSG vs. CPRX - Dividend Comparison
ENSG's dividend yield for the trailing twelve months is around 0.13%, while CPRX has not paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ENSG The Ensign Group, Inc. | 0.13% | 0.14% | 0.18% | 0.21% | 0.24% | 0.25% | 0.28% | 0.40% | 0.47% | 0.78% | 0.73% | 0.67% |
CPRX Catalyst Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
ENSG vs. CPRX - Drawdown Comparison
The maximum ENSG drawdown since its inception was -55.57%, smaller than the maximum CPRX drawdown of -94.25%. Use the drawdown chart below to compare losses from any high point for ENSG and CPRX.
Loading graphics...
Drawdown Indicators
| ENSG | CPRX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -55.57% | -94.25% | +38.68% |
Max Drawdown (1Y)Largest decline over 1 year | -12.76% | -27.29% | +14.53% |
Max Drawdown (5Y)Largest decline over 5 years | -27.41% | -45.37% | +17.96% |
Max Drawdown (10Y)Largest decline over 10 years | -55.57% | -64.87% | +9.30% |
Current DrawdownCurrent decline from peak | -6.61% | -5.89% | -0.72% |
Average DrawdownAverage peak-to-trough decline | -12.22% | -52.51% | +40.29% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.76% | 15.10% | -10.34% |
Volatility
ENSG vs. CPRX - Volatility Comparison
The current volatility for The Ensign Group, Inc. (ENSG) is 4.72%, while Catalyst Pharmaceuticals, Inc. (CPRX) has a volatility of 10.39%. This indicates that ENSG experiences smaller price fluctuations and is considered to be less risky than CPRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| ENSG | CPRX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.72% | 10.39% | -5.67% |
Volatility (6M)Calculated over the trailing 6-month period | 19.31% | 23.71% | -4.40% |
Volatility (1Y)Calculated over the trailing 1-year period | 27.37% | 34.96% | -7.59% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 26.43% | 48.24% | -21.81% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 36.03% | 62.81% | -26.78% |
Financials
ENSG vs. CPRX - Financials Comparison
This section allows you to compare key financial metrics between The Ensign Group, Inc. and Catalyst Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities